<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although <z:hpo ids='HP_0001251'>ataxia</z:hpo> is the most distressing manifestation of <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>), little is known about its natural history </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, we prospectively followed a cohort of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> for 13 months to characterize the progression of <z:hpo ids='HP_0001251'>ataxia</z:hpo> and identify its contributory factors </plain></SENT>
<SENT sid="2" pm="."><plain>The international cooperative <z:hpo ids='HP_0001251'>ataxia</z:hpo> rating scale (ICARS) was used to estimate severity of <z:hpo ids='HP_0001251'>ataxia</z:hpo> at baseline and at follow-up </plain></SENT>
<SENT sid="3" pm="."><plain>Thirty-four patients were enrolled in the study, 22 of whom were men </plain></SENT>
<SENT sid="4" pm="."><plain>Mean age at <z:hpo ids='HP_0003674'>onset</z:hpo> of the disease was 34.7 years and length of expanded CAG repeat was 66 </plain></SENT>
<SENT sid="5" pm="."><plain>Mean ICARS scores at baseline was 37.6 and at follow-up was 42.7 (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariate analysis did not find significant association of progression of disease and age at disease <z:hpo ids='HP_0003674'>onset</z:hpo>, length of expanded (CAG), or duration of disease </plain></SENT>
</text></document>